annual CAPEX:
$2.49B-$839.07M(-25.19%)Summary
- As of today (May 29, 2025), TAK annual capital expenditures is $2.49 billion, with the most recent change of -$839.07 million (-25.19%) on March 1, 2025.
- During the last 3 years, TAK annual CAPEX has risen by +$835.18 million (+50.40%).
- TAK annual CAPEX is now -46.89% below its all-time high of $4.69 billion, reached on March 31, 2023.
Performance
TAK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$611.37M+$280.56M(+84.81%)Summary
- As of today (May 29, 2025), TAK quarterly capital expenditures is $611.37 million, with the most recent change of +$280.56 million (+84.81%) on March 1, 2025.
- Over the past year, TAK quarterly CAPEX has increased by +$100.12 million (+19.58%).
- TAK quarterly CAPEX is now -81.74% below its all-time high of $3.35 billion, reached on March 31, 2023.
Performance
TAK quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$2.49B+$100.12M(+4.19%)Summary
- As of today (May 29, 2025), TAK TTM capital expenditures is $2.49 billion, with the most recent change of +$100.12 million (+4.19%) on March 1, 2025.
- Over the past year, TAK TTM CAPEX has dropped by -$839.07 million (-25.19%).
- TAK TTM CAPEX is now -59.59% below its all-time high of $6.17 billion, reached on December 31, 2023.
Performance
TAK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TAK CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.2% | +19.6% | -25.2% |
| 3 y3 years | +50.4% | +28.3% | +50.4% |
| 5 y5 years | +24.4% | +5.5% | +24.4% |
TAK CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.9% | +50.4% | -81.7% | +147.7% | -59.6% | +50.4% |
| 5 y | 5-year | -46.9% | +50.4% | -81.7% | +147.7% | -59.6% | +50.4% |
| alltime | all time | -46.9% | +920.9% | -81.7% | +590.0% | -59.6% | +2712.8% |
TAK CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $2.49B(-25.2%) | $611.37M(+84.8%) | $2.49B(+4.2%) |
| Dec 2024 | - | $330.81M(-50.3%) | $2.39B(-5.5%) |
| Sep 2024 | - | $666.19M(-24.6%) | $2.53B(+12.4%) |
| Jun 2024 | - | $883.95M(+72.9%) | $2.25B(-32.4%) |
| Mar 2024 | $3.33B(-29.0%) | $511.25M(+8.5%) | $3.33B(-46.0%) |
| Dec 2023 | - | $471.32M(+21.9%) | $6.17B(+2.2%) |
| Sep 2023 | - | $386.74M(-80.3%) | $6.04B(+2.4%) |
| Jun 2023 | - | $1.96B(-41.4%) | $5.90B(+25.6%) |
| Mar 2023 | $4.69B(+183.2%) | $3.35B(+888.1%) | $4.69B(+157.6%) |
| Dec 2022 | - | $338.83M(+37.3%) | $1.82B(-3.3%) |
| Sep 2022 | - | $246.87M(-67.5%) | $1.88B(-7.2%) |
| Jun 2022 | - | $759.22M(+59.3%) | $2.03B(+22.5%) |
| Mar 2022 | $1.66B(-25.7%) | $476.49M(+18.7%) | $1.66B(-25.3%) |
| Dec 2021 | - | $401.29M(+2.1%) | $2.22B(-1.3%) |
| Sep 2021 | - | $392.99M(+1.7%) | $2.25B(+0.3%) |
| Jun 2021 | - | $386.38M(-62.8%) | $2.24B(+0.5%) |
| Mar 2021 | $2.23B(+11.4%) | $1.04B(+141.5%) | $2.23B(+25.9%) |
| Dec 2020 | - | $429.95M(+11.4%) | $1.77B(-13.7%) |
| Sep 2020 | - | $386.06M(+2.6%) | $2.05B(+3.2%) |
| Jun 2020 | - | $376.15M(-35.1%) | $1.99B(-0.7%) |
| Mar 2020 | $2.00B(+65.6%) | $579.25M(-18.6%) | $2.00B(+8.9%) |
| Dec 2019 | - | $711.22M(+121.2%) | $1.84B(+31.5%) |
| Sep 2019 | - | $321.57M(-17.8%) | $1.40B(+9.5%) |
| Jun 2019 | - | $391.06M(-5.8%) | $1.28B(+5.6%) |
| Mar 2019 | $1.21B(+4.5%) | $415.29M(+53.6%) | $1.21B(+16.4%) |
| Dec 2018 | - | $270.31M(+34.6%) | $1.04B(+11.6%) |
| Sep 2018 | - | $200.81M(-37.9%) | $931.51M(-24.4%) |
| Jun 2018 | - | $323.31M(+32.0%) | $1.23B(+6.4%) |
| Mar 2018 | $1.16B(+11.7%) | $244.96M(+50.8%) | $1.16B(-9.3%) |
| Dec 2017 | - | $162.44M(-67.6%) | $1.28B(-10.3%) |
| Sep 2017 | - | $501.58M(+101.7%) | $1.42B(+23.6%) |
| Jun 2017 | - | $248.65M(-31.6%) | $1.15B(+11.1%) |
| Mar 2017 | $1.04B | $363.43M(+17.5%) | $1.04B(+17.8%) |
| Dec 2016 | - | $309.21M(+34.6%) | $879.64M(+17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $229.78M(+72.1%) | $748.65M(+5.1%) |
| Jun 2016 | - | $133.51M(-35.5%) | $712.03M(+0.7%) |
| Mar 2016 | $707.15M(-28.9%) | $207.15M(+16.2%) | $707.15M(-4.9%) |
| Dec 2015 | - | $178.23M(-7.7%) | $743.76M(-0.4%) |
| Sep 2015 | - | $193.16M(+50.2%) | $746.92M(+2.2%) |
| Jun 2015 | - | $128.62M(-47.2%) | $731.16M(-26.5%) |
| Mar 2015 | $994.18M(+26.8%) | $243.76M(+34.4%) | $994.18M(+1.5%) |
| Dec 2014 | - | $181.38M(+2.2%) | $979.10M(+2.9%) |
| Sep 2014 | - | $177.40M(-54.7%) | $951.59M(-7.2%) |
| Jun 2014 | - | $391.63M(+71.3%) | $1.03B(+30.8%) |
| Mar 2014 | $783.95M(-42.3%) | $228.69M(+48.6%) | $783.95M(+41.2%) |
| Dec 2013 | - | $153.87M(-38.8%) | $555.26M(+38.3%) |
| Sep 2013 | - | $251.58M(+67.9%) | $401.39M(+167.9%) |
| Jun 2013 | - | $149.81M(+61.4%) | $149.81M(-89.6%) |
| Mar 2013 | $1.36B(+50.9%) | - | - |
| Mar 2012 | $900.09M(-37.6%) | - | - |
| Mar 2011 | $1.44B(+53.9%) | $92.82M(-74.2%) | $1.44B(-14.4%) |
| Dec 2010 | - | $359.14M(-22.9%) | $1.68B(+2.7%) |
| Sep 2010 | - | $465.52M(-11.3%) | $1.64B(+19.5%) |
| Jun 2010 | - | $524.57M(+56.5%) | $1.37B(+46.5%) |
| Mar 2010 | $937.22M(+136.1%) | $335.27M(+6.4%) | $937.22M(+55.7%) |
| Dec 2009 | - | $314.99M(+58.8%) | $601.95M(+109.8%) |
| Sep 2009 | - | $198.35M(+123.9%) | $286.95M(+223.9%) |
| Jun 2009 | - | $88.61M | $88.61M |
| Mar 2009 | $396.89M(+38.7%) | - | - |
| Mar 2008 | $286.23M(+14.8%) | - | - |
| Mar 2007 | $249.36M(-12.1%) | - | - |
| Mar 2006 | $283.84M(-43.2%) | - | - |
| Mar 2005 | $500.11M(+4.1%) | - | - |
| Mar 2004 | $480.52M(+74.7%) | - | - |
| Mar 2003 | $275.01M(-8.5%) | - | - |
| Mar 2002 | $300.56M(+23.1%) | - | - |
| Mar 2001 | $244.14M(-23.6%) | - | - |
| Mar 2000 | $319.41M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual capital expenditures?
- What is the all time high annual CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual CAPEX year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly CAPEX year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM CAPEX year-on-year change?
What is Takeda Pharmaceutical Company Limited annual capital expenditures?
The current annual CAPEX of TAK is $2.49B
What is the all time high annual CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual capital expenditures is $4.69B
What is Takeda Pharmaceutical Company Limited annual CAPEX year-on-year change?
Over the past year, TAK annual capital expenditures has changed by -$839.07M (-25.19%)
What is Takeda Pharmaceutical Company Limited quarterly capital expenditures?
The current quarterly CAPEX of TAK is $611.37M
What is the all time high quarterly CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly capital expenditures is $3.35B
What is Takeda Pharmaceutical Company Limited quarterly CAPEX year-on-year change?
Over the past year, TAK quarterly capital expenditures has changed by +$100.12M (+19.58%)
What is Takeda Pharmaceutical Company Limited TTM capital expenditures?
The current TTM CAPEX of TAK is $2.49B
What is the all time high TTM CAPEX for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM capital expenditures is $6.17B
What is Takeda Pharmaceutical Company Limited TTM CAPEX year-on-year change?
Over the past year, TAK TTM capital expenditures has changed by -$839.07M (-25.19%)